Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
135.79
+0.22 (0.16%)
At close: Jan 9, 2026, 4:00 PM EST
135.80
+0.01 (0.01%)
After-hours: Jan 9, 2026, 5:38 PM EST
Neurocrine Biosciences Analyst Ratings
Total Analysts
21
Consensus Rating
Strong Buy
Price Target
$177.14
Upside
+30.45%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $172 → $169 | Strong Buy | Maintains | $172 → $169 | +24.46% | Jan 8, 2026 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $173 → $175 | Buy → Hold | Downgrades | $173 → $175 | +28.88% | Jan 8, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $168 → $198 | Strong Buy | Maintains | $168 → $198 | +45.81% | Dec 17, 2025 |
| Mizuho | Mizuho | Hold Maintains $146 → $175 | Hold | Maintains | $146 → $175 | +28.88% | Dec 12, 2025 |
| Stifel | Stifel | Strong Buy Maintains $183 → $188 | Strong Buy | Maintains | $183 → $188 | +38.45% | Dec 11, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $160 → $180 | Buy | Maintains | $160 → $180 | +32.56% | Dec 8, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $175 → $200 | Strong Buy | Maintains | $175 → $200 | +47.29% | Dec 5, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $178 → $173 | Buy | Maintains | $178 → $173 | +27.40% | Nov 11, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $171 → $179 | Buy | Maintains | $171 → $179 | +31.82% | Nov 3, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $165 → $172 | Strong Buy | Reiterates | $165 → $172 | +26.67% | Oct 30, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $160 → $164 | Strong Buy | Maintains | $160 → $164 | +20.77% | Oct 29, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $175 → $203 | Strong Buy | Maintains | $175 → $203 | +49.50% | Oct 29, 2025 |
| Stifel | Stifel | Strong Buy Maintains $174 → $183 | Strong Buy | Maintains | $174 → $183 | +34.77% | Oct 29, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $156 → $160 | Buy | Maintains | $156 → $160 | +17.83% | Oct 29, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $175 → $179 | Buy | Maintains | $175 → $179 | +31.82% | Oct 29, 2025 |
| Needham | Needham | Strong Buy Maintains $170 → $184 | Strong Buy | Maintains | $170 → $184 | +35.50% | Oct 29, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.